Securing a reliable vendor for pharmaceutical intermediates in bulk quantities is a critical element of efficient and cost-effective drug manufacturing. Many firms prefer to subcontract this portion of their operations to focused providers who have the essential infrastructure, knowledge and regulatory standards. The consistent availability of thes